All Posts By

Smartkarma Daily Briefs

Jul 28
0

Daily Brief Consumer: Tohokushinsha Film, Fancl Corp, TSE Tokyo Price Index TOPIX, Tesla and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Tohokushinsha Film (2329 JP): Potential Scenarios as 3D Lobs a Privatisation Proposal
  • Weekly Deals Digest (28 Jul) – Fancl, Furukawa Battery, Sun Corp, TFC, Canvest, CPMC, GAPack, Arvida
  • What Investors and Companies Should Do to Make Engagement More Effective ….
  • Tesla’s Bold Ambitions vs. Harsh Realities Of Product Delays & Slowing Growth Of EV Demand! – Major Drivers

Tohokushinsha Film (2329 JP): Potential Scenarios as 3D Lobs a Privatisation Proposal

By Arun George

  • On 24 July, 3D Investment Partners proposed to privatise Tohokushinsha Film (2329 JP) through a tender offer at JPY600-650 per share. A special committee will evaluate the proposal. 
  • 3D’s privatisation plan, in its current terms, is a non-starter as the price is low, and its activism campaign has so far been met with the Board’s scepticism.
  • The possible scenarios are that a white knight emerges to buy 3D’s stake/launch a counteroffer, 3D bumps the offer price, or the Board introduces a more ambitious MTM plan.

Weekly Deals Digest (28 Jul) – Fancl, Furukawa Battery, Sun Corp, TFC, Canvest, CPMC, GAPack, Arvida

By Arun George

What Investors and Companies Should Do to Make Engagement More Effective ….

By Aki Matsumoto

  • The high percentage of foreign ownership is a characteristic of companies that have improved capital profitability and increased valuations, which is effective for overseas investor engagement.
  • If the system is revised to help collaborative engagement and the identification of substantial shareholders, some of the challenges will be eliminated for both investors and the company.
  • To make the engagement more effective, investors should increase active funds and companies should decrease cross-shareholdings.

Tesla’s Bold Ambitions vs. Harsh Realities Of Product Delays & Slowing Growth Of EV Demand! – Major Drivers

By Baptista Research

  • Tesla remains a polarizing entity in the stock market, consistently capturing the imagination of investors with its bold vision and ambitious projects.
  • The company’s latest earnings highlighted both its impressive achievements and notable challenges, leaving a mixed bag for potential investors, resulting in the stock going down.
  • On the positive side, Tesla continues to lead the electric vehicle (EV) market with record revenues and promising advancements in autonomous driving technology.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 28
0

Daily Brief Financials: Mandala Multifinance, Molten Ventures and more

By | Daily Briefs, Financials

In today’s briefing:

  • Mandala Multifinance (MFIN IJ): Offer Now Open
  • Molten Ventures – Making progress on its realisation agenda

Mandala Multifinance (MFIN IJ): Offer Now Open

By David Blennerhassett

  • Waaay back in June 2023, MUFG (8306 JP) and 92.7%-held Adira Dinamika (ADMF IJ) entered into SPAs with key shareholders to acquire an 80.6% stake in Mandala Multifinance (MFIN IJ).
  • MFIN’s shareholders overwhelmingly approved the change of control at the 13th Feb EGM. OJK signing off was the next hurdle.
  • The Tender Offer is now open, at the (expected) price of  IDR 3,297/share. The close of the Offer is the 21st August, with payment on the 28th August. 

Molten Ventures – Making progress on its realisation agenda

By Edison Investment Research

Molten Ventures has recently completed the exits from Perkbox, Endomag and Graphcore. This translates into more than £70m realisation proceeds, which means Molten is on track to reach the £100m that management expects for FY25. As a result, Molten has announced a £10m buyback programme (starting on 26 July), in line with its recently updated capital allocation policy of earmarking at least 10% of realisation proceeds for share repurchases. Molten has also agreed a new £180m debt facility that replaces the previous £150m facility maturing in September 2024.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 28
0

Daily Brief Health Care: Arvida, Dr. Reddy’s Laboratories, Jeisys Medical, OSE Immuno and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • (Mostly) Asia-Pac M&A: Furukawa Battery, Arvida, Warehouse Group, Pacific Smiles, Canvest, Jeisys
  • Quiddity Leaderboard NIFTY Sep 24: Final Expectations; Trades Perform Positively; New Ideas
  • Last Week in Event SPACE: Sun Corp, Amorepacific, Canon Marketing, Jeisys Medical
  • OSE Immunotherapeutics – Lusvertikimab shines in Phase II UC trial

(Mostly) Asia-Pac M&A: Furukawa Battery, Arvida, Warehouse Group, Pacific Smiles, Canvest, Jeisys

By David Blennerhassett

Quiddity Leaderboard NIFTY Sep 24: Final Expectations; Trades Perform Positively; New Ideas

By Janaghan Jeyakumar, CFA

  • NIFTY 50 represents the 50 largest stocks listed in the National Stock Exchange (NSE) of India and the NIFTY Next 50 index tracks the next 50 largest names.
  • With three more trading days left in the reference period, we are presenting our final  expectations for ADDs and DELs for the September 2024 index rebal event.
  • We see five changes for the NIFTY 100 index which will also affect the NIFTY Next 50 index. There could also be multiple changes for the NIFTY 50 index.

Last Week in Event SPACE: Sun Corp, Amorepacific, Canon Marketing, Jeisys Medical

By David Blennerhassett

OSE Immunotherapeutics – Lusvertikimab shines in Phase II UC trial

By Edison Investment Research

OSE Immunotherapeutics’ run of positive news continues with the announcement of encouraging data from the Phase II proof-of-concept CoTikiS study, evaluating Lusvertikimab as a novel treatment for ulcerative colitis (UC). The randomised, double-blind trial (n=136) has reported encouraging, statistically significant benefits, reflected in material improvements on the Modified Mayo Score (MMS). The full data set will be presented in due course, and we expect the next stage of development to be undertaken in partnership, which we estimate will be in place in 2025. Lusvertikimab is a potentially first-in-class IL-7R antagonist, offering a differentiated mechanism of action to other available biologics that currently dominate the UC market. We expect the next major catalyst for OSE to be the initiation of the Phase III trial for lead asset Tedopi, anticipated to commence imminently (previous guided timeline was Q224).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief Quantitative Analysis: Hong Kong Buybacks Weekly (Jul 26th): Meituan and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • Hong Kong Buybacks Weekly (Jul 26th): Meituan, Aia, Hsbc

Hong Kong Buybacks Weekly (Jul 26th): Meituan, Aia, Hsbc

By Ke Yan, CFA, FRM

  • We analyze statistics on top repurchases over one week, one month, one quarter and one year periods ended on Jul 26th based on HKEx daily reports.
  • In the past 7 days, the top 3 companies that repurchased the most shares from the market were Meituan (3690 HK), AIA (1299 HK), HSBC (5 HK).
  • In the past 30 days, the top 3 companies that repurchased the most shares from the market were Tencent (700 HK), Meituan (3690 HK), AIA (1299 HK).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief Thematic (Sector/Industry): Japan Weekly | Renesas and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Weekly | Renesas, Ibiden Get Slammed in Tech Rout
  • [Blue Lotus Daily-TMT Update]:1797 HK/JD US/BABA US/PDD US/3690 HK/1024HK/700HK/NTE US/TCOMUS/AMZNUS
  • [CB 29/2024]: Wheat Pressured,Corn Rallies,Soybean Remains Volatile on Political & China Uncertainty
  • China’s AI Models Struggle to Bring Transformative Use, Executive Says
  • # 35 India Insight: Bajaj Auto Investment, Emami Acquire Man Company, WeWork India New Workspaces
  • AUCTUS ON FRIDAY – 26/07/2024
  • HK RE Series (3): Global Macro Starts to Turn More Supportive, Stock Valuation Is Compelling
  • [Blue Lotus Daily]:1810 HK/AAPL/981 HK/LKNCY US/BZ US/LI US/1211 HK
  • Challenging Time for Trust Firms as Six Out of 10 Report Weaker Results

Japan Weekly | Renesas, Ibiden Get Slammed in Tech Rout

By Mark Chadwick

  • The Topix declined by 5.6%, while the Nikkei lost almost 2,400 points, or 6%. However, equities took a back seat to the FX market
  • Given the currency movements and the global tech sell-off, it’s no surprise that the worst performers were semiconductors (-10%) and autos (-9%).
  • The recent market movements appear to have been driven primarily by macro events, particularly the yen’s reversal, which impacted high beta and momentum stocks.

[Blue Lotus Daily-TMT Update]:1797 HK/JD US/BABA US/PDD US/3690 HK/1024HK/700HK/NTE US/TCOMUS/AMZNUS

By Ying Pan

  • 1797 HK/JD US: Popular live streamer Dong Yuhui leaves East Buy (-/+)
  • BABA US/PDD US: AliExpress receives small fine in Korea due to data privacy violation (+)
  • Chinese Gaming Industry: Games Can Now Be Filed for Testing Without Approval of Game Code, Guangdong Province Leads the Way  (+)

[CB 29/2024]: Wheat Pressured,Corn Rallies,Soybean Remains Volatile on Political & China Uncertainty

By Amrutha Raj

  • Wheat trading sideways on weather concerns, but bearish sentiment driven by ample supplies is likely to prevail.
  • Corn prices rally significantly driven by unfavorable weather conditions and strong export demand. Analysts expect bearish turnaround.
  • Soybeans recover on US presidential election uncertainty; but speculation is overshadowed by persistent concerns over Chinese demand.

China’s AI Models Struggle to Bring Transformative Use, Executive Says

By Caixin Global

  • Industry executives attending the World AI Conference in Shanghai expressed concerns about recurring technological issues in the development of large language models (LLMs) and offered possible solutions, as demand for more reliable artificial intelligence (AI) models designed for sector-specific software grows stronger.
  • The issues also come as China’s tech titans have kicked off a new round of price cuts for their AI models, extending a fierce price war in an effort not to lead the industry but to gain more users for their cloud businesses — a key resource for AI developers.
  • Xu Li, CEO of Chinese facial recognition and AI specialist SenseTime Group Inc.

# 35 India Insight: Bajaj Auto Investment, Emami Acquire Man Company, WeWork India New Workspaces

By Sudarshan Bhandari

  • Bajaj Auto to invest INR 800 crore in Maharashtra to boost electric three-wheeler production.
  • Emami plans to fully acquire The Man Company, enhancing its digital-first brand portfolio.
  • WeWork India to launch new workspaces in Bengaluru and Noida, addressing flexible workspace demand.

AUCTUS ON FRIDAY – 26/07/2024

By Auctus Advisors

  • AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target of A$0.75 per share: Diversified and high impact newsflow over the balance of 2024 – ADX has confirmed a very busy programme of activity from September.
  • The overall unrisked value of the programme is ~A$1.70 per share, which represents 17x the current share price.
  • In early September, ADX will drill the Anshof-2A side track.

HK RE Series (3): Global Macro Starts to Turn More Supportive, Stock Valuation Is Compelling

By Jacob Cheng

  • We look at the global macro themes that are impacting the equity market including the US election, the Fed and China’s latest rate cut
  • We also look at the latest condition in Hong Kong, including the rates, the economy and the physical RE market
  • HK RE stocks continue to trade at compelling valuation, but fund flows are needed if we want a re-rating

[Blue Lotus Daily]:1810 HK/AAPL/981 HK/LKNCY US/BZ US/LI US/1211 HK

By Eric Wen

  • 1810 HK/AAPL: Xiaomi’s China unit volume grew 17% yoy in 2Q (+/-)
  • 1810 HK: Xiaomi acquires more land to build another EV factory (+)
  • 981 HK/1810 HK: SMIC’s upcoming “5nm” process to feature significant efficiency improvement (+/-)

Challenging Time for Trust Firms as Six Out of 10 Report Weaker Results

By Caixin Global

  • Nearly six out of 10 of China’s trust companies saw their revenue and profit decline in the first half of 2024, reflecting challenges amid a regulator crackdown on an industry plagued by scandals.
  • Among the 53 trust companies that have published their unaudited first half financial results, 13 reported net profits of less than 100 million yuan ($13.8 million) and three posted net losses.
  • About 60% of trust companies saw year-on-year declines in operating revenue, total profit and net profit in the first half, underscoring significant business pressure and performance disparities among companies, according to a research report by China Credit Trust Co.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief Technical Analysis: Pullback Underway; Getting Defensive; Long-Term RS Bottoms for Defensives Is a Reason for Caution and more

By | Daily Briefs, Technical Analysis

In today’s briefing:

  • Pullback Underway; Getting Defensive; Long-Term RS Bottoms for Defensives Is a Reason for Caution

Pullback Underway; Getting Defensive; Long-Term RS Bottoms for Defensives Is a Reason for Caution

By Joe Jasper

  • Our long-term bullish outlook (since early-November 2023) remains intact. With that said, we believe a 1-3-month pullback has likely begun.
  • Supports to watch are at $110 on MSCI ACWI (ACWI-US) and $41-42 on MSCI EM (EEM-US), and whether these levels hold or not will determine the severity of the pullback.
  • The S&P 500 is violating its 20-day MA, Europe’s EURO STOXX 50 is breaking below 4884, and Japan’s TOPIX appears to be staging a false breakout at the 2800-2815 level

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief ESG: Rexel – ESG Report – Lucror Analytics and more

By | Daily Briefs, ESG

In today’s briefing:

  • Rexel – ESG Report – Lucror Analytics

Rexel – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We assess Rexel’s ESG as “Strong”, in line with its Social and Governance scores, while the Environmental score is “Adequate”. Controversies are “Immaterial” and Disclosure is “Strong”. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief ECM: Akums Drugs and Pharmaceuticals IPO – RHP Updates & Quick Thoughts on Peer Comp and Valuation and more

By | Daily Briefs, ECM

In today’s briefing:

  • Akums Drugs and Pharmaceuticals IPO – RHP Updates & Quick Thoughts on Peer Comp and Valuation
  • Akums Drugs and Pharmaceuticals IPO: Subscribe on Favorable Industry Tailwind and Reasonable Pricing

Akums Drugs and Pharmaceuticals IPO – RHP Updates & Quick Thoughts on Peer Comp and Valuation

By Ethan Aw

  • Akums Drugs and Pharmaceuticals (0200361D IN) is looking to raise up to US$222m in its upcoming India IPO.
  • Akums Drugs and Pharmaceuticals (ADP) is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • In our previous note, we talked about the company’s historical performance. In this note, we talk about its RHP updates and share our quick thoughts on peer comparison and valuation.

Akums Drugs and Pharmaceuticals IPO: Subscribe on Favorable Industry Tailwind and Reasonable Pricing

By Tina Banerjee

  • Akums Drugs and Pharmaceuticals, the largest India-focused CDMO, has set price band of Rs 646–679/share for its upcoming IPO. The company has blue chip and sticky clientele.
  • The Indian domestic CDMO market is forecasted to grow at a CAGR of 14.3% during FY24–28, nearly doubling its historical growth rate.
  • Akums seeks a P/E valuation of 28.7–30.2x, which seems to be reasonable compared with listed peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief Event-Driven: StubWorld’s: Amorepacific’s NAV Discount Plumbs New Multi-Year Low and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • StubWorld’s: Amorepacific’s NAV Discount Plumbs New Multi-Year Low
  • Zhihu (2390 HK/ZH US)’s Cheeky Buyback
  • Doosan Bobcat Employees Involved In Major Breach of Duty + Doosan Group Pushes Ahead With Merger
  • Tatsuta Electric (5809 JP): Eneos Returns with a Token Bump to JPY780
  • EQD | WHAT IF The NIFTY Starts to Pullback This Week?
  • STOXX 600: First September Forecasts for Europe and Eurozone

StubWorld’s: Amorepacific’s NAV Discount Plumbs New Multi-Year Low

By David Blennerhassett

  • A double dose of StubWorld this week: both the implied stub for Amorepacific Group (002790 KS) and the simple ratio (Group/Amorepacific Corp (090430 KS)) are around lifetime low levels.
  • Preceding my comments on Amorepacific are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Zhihu (2390 HK/ZH US)’s Cheeky Buyback

By David Blennerhassett

  • Back on the 19th July, online Q&A play Zhihu (2390 HK/ZH US) announced the buyback of 46.92mn ordinary A shares (15.9% of shares out) at HK$9.11/share (US$3.50/ADS). 
  • Assuming the buyback is fully taken up, chairman Yuan Zhou’s stake will increase to 44.4% from 42.9% currently (held via A shares and the weighted-voting B shares). 
  • The key condition is a simple majority vote from independent shareholders. Zhihu is sitting on  net cash of US$764mn. A significantly larger buyback, or higher price, could have been initiated. 

Doosan Bobcat Employees Involved In Major Breach of Duty + Doosan Group Pushes Ahead With Merger

By Douglas Kim

  • On 26 July, it was reported in the local media that there has been a major breach of duty by nearly 40 current/former employees at Doosan Bobcat.
  • The fact that this material breach of duty was not revealed prior to the merger announcement adds to the argument that this merger/split/delisting should be either cancelled or redone. 
  • We remain negative on all major companies involved in this deal including Doosan Bobcat and Doosan Robotics. The breach of duty at Doosan Bobcat adds to the fire. 

Tatsuta Electric (5809 JP): Eneos Returns with a Token Bump to JPY780

By Arun George

  • ENEOS Holdings (5020 JP) has increased the Tatsuta Electric Wire & Cable (5809 JP) tender offer price by 8.3% to JPY780 and extended the offer period to 19 August.
  • Eneos tried to get the required acceptances by refusing to bump and subsequently extending the offer period. The tactics failed as minorities required a bump due to the market re-rating. 
  • While the revised offer remains light, the token bump and deal fatigue should suffice to nudge the marginal vote to accept. At the last close, the gross/annualised spread was 5.0%/85.8%.

EQD | WHAT IF The NIFTY Starts to Pullback This Week?

By Nico Rosti

  • The NIFTY Index defied gravity and kept rallying higher for the past 8 weeks. According to our models it’s massively OVERBOUGHT and has been so for a while.
  • While many other Asian markets have pulled back decisively, the NIFTY is just going higher and higher.
  • Assuming it has its own uncorrelated drivers, where would it be a BUY again, if it pulls back this coming week? Let’s discuss this in this WEEKLY insight.

STOXX 600: First September Forecasts for Europe and Eurozone

By Dimitris Ioannidis

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free


Jul 27
0

Daily Brief Equity Bottom-Up: Tencent/Netease: Zero for Major Names; Industry Revenue Growth Flattish in First Half and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Tencent/Netease: Zero for Major Names; Industry Revenue Growth Flattish in First Half
  • The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (July 26)
  • Consumer Tales #July21-26:Apple Falls from Top 5 in China, Xiaomi Tops India Smartphones
  • [Meituan (3690 HK, BUY, TP HK$160) TP Change]: Resilient Catering & Eased Competition Support Growth
  • Taiwan Semiconductor (TSMC): How Will They Deal With The Strained Production Capacity & Geopolitical Risks & Regulatory Pressures? – Major Drivers
  • AST SpaceMobile’s 25% Jump: A Satellite Breakthrough Investors Can’t Ignore!
  • [Kanzhun (BZ US, BUY, TP US$19) TP Change]: Impacted by Poor Macro but Still on Top of Competition
  • [Earnings Preview] BP’s Woes Continue: Weak Refining Margins to Squeeze Earnings
  • Tech Supply Chain Tracker (27-Jul-2024): ST cuts 2024 outlook as demand slows.
  • Netflix Inc.: Expanding Content Library & Global Reach For Continued Global Dominance! – Major Drivers

Tencent/Netease: Zero for Major Names; Industry Revenue Growth Flattish in First Half

By Ke Yan, CFA, FRM

  • China announced game approval for the June batch. The number of games approved remained at a higher level than 2023.
  • The pace of China game approval appears to have accelerated to the same level as pre-tightening. Of companies that we are monitoring, none got any approval.
  • China’s CADPA published a semi-annual report pointing to flattish growth of gaming revenue in the first half. 

The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (July 26)

By David Mudd

Consumer Tales #July21-26:Apple Falls from Top 5 in China, Xiaomi Tops India Smartphones

By Devi Subhakesan

  • Welcome to Consumer Tales & Trends, your weekly roundup of the latest corporate developments, investment reports and sector events in the consumer industry.
  • An interesting comparison between China and India smart phone markets in 2Q 2024 – highlighting differences in market size and the dominance of leading players.
  • Xiaomi Corp(1810 HK)  made a strong come back in 2Q24 in terms of sales in both the markets. In China, it saw a 17% year-on-year increase, shipping 10 million units.

[Meituan (3690 HK, BUY, TP HK$160) TP Change]: Resilient Catering & Eased Competition Support Growth

By Ying Pan

  • We expect Meituan’s C2Q24 rev. and non-IFRS NI to be 0.7% and 12.3% higher than cons, driven by resilient catering demand and eased competition.
  • We expect Meituan in-store OPM improve to 33%/35% in 2Q24/2H24 supported by increasing commission rate and cutting BD cost.
  • We maintain the stock as BUY rating and raise TP by HK$4 to HK$160/share to factor in the better profitability.

Taiwan Semiconductor (TSMC): How Will They Deal With The Strained Production Capacity & Geopolitical Risks & Regulatory Pressures? – Major Drivers

By Baptista Research

  • Taiwan Semiconductor Manufacturing Company’s (TSMC) second quarter 2024 results reveal a mixed picture of advances and challenges.
  • The revenue for the quarter was notably strong, increasing by 13.6% sequentially in NT or 10.3% in U.S. dollars.
  • This substantial growth was fueled by robust demand for the cutting-edge 3- and 5- nanometer technologies, although somewhat offset by smartphone seasonality.

AST SpaceMobile’s 25% Jump: A Satellite Breakthrough Investors Can’t Ignore!

By Baptista Research

  • AST SpaceMobile has recently made headlines with a significant leap in its ambitious mission to build the world’s first space-based cellular broadband network.
  • The company has announced the successful completion and upcoming shipment of its first five commercial satellites, marking a pivotal milestone that has already caused its stock to surge by nearly 25%.
  • These satellites, known as Bluebirds, are set to provide unprecedented global connectivity directly to standard mobile devices, bridging the digital divide and offering broadband services in previously unreachable areas.

[Kanzhun (BZ US, BUY, TP US$19) TP Change]: Impacted by Poor Macro but Still on Top of Competition

By Eric Wen

  • Due to weakening hiring demand from both manufacturing and service, we expect BZ’s cash billing to decline 5% QoQ in 2Q24, 9% below consensus. 
  • We believe BZ’s user matrices still growing and leading. The weakness is mainly attributable to the employer/hiring side;
  • We cut TP by US$3 to US$19/ADS while keep the BUY rating.

[Earnings Preview] BP’s Woes Continue: Weak Refining Margins to Squeeze Earnings

By Suhas Reddy

  • BP expects lower realised refining margins and weak oil trading to hurt earnings, with a refining margin contraction to reduce earnings by USD 500-700 million.
  • The company anticipates impairments ranging from USD 1-2 billion in Q2, including charges related to the ongoing review of its Gelsenkirchen refinery in Germany.
  • BP projects its upstream production to remain broadly flat sequentially, with stable oil output and a slight decrease in gas and low-carbon energy production.

Tech Supply Chain Tracker (27-Jul-2024): ST cuts 2024 outlook as demand slows.

By Tech Supply Chain Tracker

  • ST reduces 2024 outlook amid industrial and automotive slowdown, impacting company’s future projections.
  • VCs discuss Taiwan startups in AI industry, highlighting challenge of staying competitive in fast-evolving sector.
  • Global regulators collaborate to address market dominance of AI giants, emphasizing need for fair competition and consumer protection.

Netflix Inc.: Expanding Content Library & Global Reach For Continued Global Dominance! – Major Drivers

By Baptista Research

  • Netflix reported its financial performance for the second quarter, highlighting key metrics that provide insights into its current standing and future direction.
  • The company reported earnings per share of $4.88, exceeding Wall Street’s expectation of $4.74.
  • Revenue for the quarter stood at $9.56 billion, slightly above the anticipated $9.53 billion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Sign Up for Free